The investment seeks investment results that correspond generally to the performance, before fees and expenses, of the MSCI EAFE U... Show more
The Xtrackers MSCI EAFE Hedged Equity ETF tracks the MSCI EAFE US Dollar Hedged Index, which provides exposure to large- and mid-cap equities across developed markets outside North America — Europe, Australasia, and the Far East — while neutralizing fluctuations between the U.S. dollar and foreign currencies. The fund carries a net expense ratio of 0.35% and manages roughly $9.2 billion in assets across more than 700 holdings, using a passive, index-replication approach.
Geographically, Japan is the single largest country weight at roughly 22% to 25%, followed by the United Kingdom (about 14%), France, Switzerland, and Germany (each near 9% to 10%), with smaller positions in Australia and the Netherlands. From a sector perspective, financials dominate at roughly a quarter of assets, followed by industrials (about 19%) and technology (around 12%), with healthcare, consumer discretionary, and consumer staples providing additional balance.
Top holdings include semiconductor-equipment leader ASML, European pharmaceutical giants AZN (AstraZeneca), NVS (Novartis), and Roche, plus global banks HSBC and MUFG (Mitsubishi UFJ Financial), energy major SHEL (Shell), software leader SAP, automaker TM (Toyota), and diversified miner BHP. This blend of value-oriented financials, export-sensitive industrials, and high-margin healthcare and technology positions the fund to benefit from a stabilizing rate environment and resilient corporate earnings.
Several developments could shape the fund's trajectory in the coming months. First, European Central Bank policy remains pivotal: further rate cuts would compress net interest margins for European banks such as HSBC and Banco Santander, a core part of the financials allocation, while simultaneously supporting equity valuations and consumer spending across the eurozone.
Second, Bank of Japan normalization is a double-edged catalyst. Gradual rate hikes and a firmer yen would normally pressure Japanese exporters; however, because the fund hedges currency exposure, investors capture the local-market earnings of companies like Toyota and MUFG more directly. Higher Japanese rates also tend to benefit domestic financial institutions.
Third, semiconductor and AI-driven demand for advanced lithography equipment influences ASML, the fund's largest single equity position. Any shift in chip-equipment capex (capital expenditure) cycles or export-control policy could ripple through the technology sleeve.
Finally, European earnings seasons, corporate buybacks, and ongoing index rebalancing represent recurring catalysts. Net outflows in recent months, however, signal that investor sentiment toward currency-hedged developed-market exposure has cooled, a dynamic that could influence secondary-market liquidity and short-term pricing.
The macro environment for the fund's underlying index is defined by regional divergence. A slowing eurozone economy has pushed the ECB toward accommodation, which historically supports European equities but compresses bank profitability. In contrast, Japan's exit from ultra-loose policy supports financials and reflects stronger domestic demand, a constructive backdrop for the fund's largest geographic sleeve.
Inflation remains a central variable. Persistent price pressures could delay ECB easing, while a weaker U.S. dollar cycle — if it materializes — would be largely neutralized by the fund's hedge, making local earnings growth the primary return engine. The financials-heavy allocation means the index's future outlook is closely tied to the shape of global yield curves, while the industrials and technology weightings link performance to trade volumes, infrastructure spending, and the semiconductor cycle.
From an index perspective, developed international equities continue to trade at a valuation discount to U.S. large caps, a factor some strategists view as supportive of long-term relative returns. However, the currency hedge means the fund will not capture gains from any foreign-currency appreciation, a structural trade-off investors should weigh when comparing hedged and unhedged EAFE (Europe, Australasia, Far East) exposure.
Tickeron's Trend Prediction Engine is an AI-powered forecasting tool designed to help traders assess whether a stock, ETF, or other tradable asset may trend bullish, bearish, or sideways over the coming week or month. The engine analyzes market data to identify developing trends, potential breakouts or reversals, and directional signals across a broad universe of instruments. Users can explore searchable prediction categories, review historical context, and leverage alert-oriented functionality to stay informed as conditions evolve. For investors tracking currency-hedged developed-market exposure, the engine offers a data-driven complement to fundamental research. Explore the Trend Prediction Engine to see how AI-based forecasting can inform your market monitoring.
Over a longer horizon, several structural forces could influence the fund. Demographic aging across Europe and Japan supports steady demand for healthcare and dividend-generating financials, both meaningful portfolio weights. The global transition toward advanced semiconductor manufacturing underpins ASML's long-term demand, while electrification and energy-transition spending benefit industrial and utility holdings.
Interest-rate cycles will remain a defining variable: a prolonged higher-rate environment favors the fund's banking and insurance exposures, whereas a deep cutting cycle could compress those same profit pools. Japan's corporate-governance reforms continue to encourage buybacks and improved shareholder returns, a structural tailwind for its large weight in the index. At the same time, currency hedging remains the fund's defining feature, making it most suitable for investors seeking developed-market diversification without foreign-exchange volatility. These trends shape the index's long-term outlook without implying any specific return target.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| JPXN | 99.61 | 1.30 | +1.33% |
| iShares JPX-Nikkei 400 ETF (JPXN) | |||
| MDYV | 94.94 | 0.55 | +0.58% |
| State Street SPDR S&P 400 Mid Cap Value ETF (MDYV) | |||
| CMBS | 47.63 | -0.03 | -0.06% |
| iShares CMBS ETF (CMBS) | |||
| FSZ | 83.08 | -0.07 | -0.08% |
| First Trust Switzerland AlphaDEX Fund (FSZ) | |||
| BMNZ | 6.50 | -1.01 | -13.45% |
| Defiance Daily Target 2X Short BMNR ETF (BMNZ) | |||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BMNZ | 6.50 | -1.01 | -13.45% |
| Defiance Daily Target 2X Short BMNR ETF (BMNZ) | |||
| FSZ | 83.08 | -0.07 | -0.08% |
| First Trust Switzerland AlphaDEX Fund (FSZ) | |||
| CMBS | 47.63 | -0.03 | -0.06% |
| iShares CMBS ETF (CMBS) | |||
| MDYV | 94.94 | 0.55 | +0.58% |
| State Street SPDR S&P 400 Mid Cap Value ETF (MDYV) | |||
| JPXN | 99.61 | 1.30 | +1.33% |
| iShares JPX-Nikkei 400 ETF (JPXN) | |||
A.I.dvisor indicates that over the last year, DBEF has been closely correlated with EFA. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if DBEF jumps, then EFA could also see price increases.
| Ticker / NAME | Correlation To DBEF | 1D Price Change % | ||
|---|---|---|---|---|
| DBEF | 100% | +0.90% | ||
| EFA - DBEF | 93% Closely correlated | +0.29% | ||
| VEA - DBEF | 93% Closely correlated | +0.81% | ||
| IEFA - DBEF | 93% Closely correlated | +0.28% | ||
| VEU - DBEF | 91% Closely correlated | +0.93% | ||
| SCHF - DBEF | 91% Closely correlated | +0.82% | ||
More | ||||
DBEF broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 42 similar instances where the stock broke above the upper band. In 32 of the 42 cases the stock fell afterwards. This puts the odds of success at 76%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DBEF declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.
The Aroon Indicator for DBEF entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on DBEF as a result. In 71 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
The Moving Average Convergence Divergence (MACD) for DBEF just turned positive on November 09, 2026. Looking at past instances where DBEF's MACD turned positive, the stock continued to rise in 43 of 47 cases over the following month. The odds of a continued upward trend are 90%.
DBEF moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for DBEF crossed bullishly above the 50-day moving average on November 11, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 87%.
Following a +1.46% 3-day Advance, the price is estimated to grow further. Considering data from situations where DBEF advanced for three days, in 284 of 343 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.